Molecular Devices launches next-gen monoclonal verification imaging platform for automatic, day zero monoclonality assurance
San Jose, Calif. (PRWEB) January 24, 2022 -- Molecular Devices, LLC., a leading provider of high-performance life science solutions, has officially launched
Source: prweb.com